Trends in add-on medications following metformin monotherapy for type 2 diabetes

BACKGROUND: Although metformin is generally universally recommended as a first-line pharmacologic therapy for most people living with type 2 diabetes, second-line and third-line choices can require a tailored approach to achieve optimal blood glucose and glycated hemoglobin levels. OBJECTIVE: To exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Swart, Elizabeth CS, Neilson, Lynn M, Munshi, Kiraat D, Peasah, Samuel K, Henderson, Rochelle, Good, Chester B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373027/
https://www.ncbi.nlm.nih.gov/pubmed/36282929
http://dx.doi.org/10.18553/jmcp.2022.28.11.1253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373027/
https://www.ncbi.nlm.nih.gov/pubmed/36282929
http://dx.doi.org/10.18553/jmcp.2022.28.11.1253

Ejemplares similares